Pages that link to "Q36311077"

The following pages link to Development of Diagnostic Biomarkers for Detecting Diabetic Retinopathy at Early Stages Using Quantitative Proteomics (Q36311077):

Displaying 10 items.

• Tear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicine (Q26740411) (← links)
• Machine Learning and Data Mining Methods in Diabetes Research (Q31157922) (← links)
• Plasma Clusterin and the CLU Gene rs11136000 Variant Are Associated with Mild Cognitive Impairment in Type 2 Diabetic Patients (Q37131933) (← links)
• Roles of exosomes in the normal and diseased eye. (Q38688358) (← links)
• A Quantitative Proteomics Approach to Clinical Research with Non-Traditional Samples (Q41832554) (← links)
• GLP-1 Treatment Improves Diabetic Retinopathy by Alleviating Autophagy through GLP-1R-ERK1/2-HDAC6 Signaling Pathway (Q46148961) (← links)
• Multiplex Biomarker Approaches in Type 2 Diabetes Mellitus Research (Q51091532) (← links)
• Change of ranibizumab-induced human vitreous protein profile in patients with proliferative diabetic retinopathy based on proteomics analysis. (Q54965847) (← links)
• A rapid non-target screening method for determining prohibited substances in human urine using liquid chromatography/high-resolution tandem mass spectrometry (Q57160035) (← links)
• Plasma Gelsolin: Indicator of Inflammation and Its Potential as a Diagnostic Tool and Therapeutic Target (Q58702505) (← links)